Early cytokine elevation, prpres deposition, and gliosis in mouse scrapie: No effect on disease by deletion of cytokine genes IL-12p40 and IL-12p35

Journal of Virology

Volumn 86, Issue 19, 2012, Pages 10377-10383

  Tribouillard Tanvier, Déborah ^a,b   Race, Brent ^a   Striebe, James F ^a   Carroll, James A ^a   Phillips, Katie ^a   Chesebro, Bruce ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b French Blood Agency   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PRION PROTEIN; PROTEASE RESISTANT PRION PROTEIN; RANTES; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN LEVEL; BRAIN SPONGIOSIS; CONTROLLED STUDY; CYTOKINE RESPONSE; FEMALE; GENE DELETION; GENE EXPRESSION; GENETIC CODE; GLIOSIS; IL 12P35 GENE; IL 12P40 GENE; IMMUNOHISTOCHEMISTRY; INOCULATION; KNOCKOUT MOUSE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCRAPIE; SURVIVAL TIME; TERMINAL DISEASE; VIRUS STRAIN;

ANIMALS; BRAIN; CHEMOKINE CCL3; CHEMOKINE CXCL1; CYTOKINES; FEMALE; GENE DELETION; GLIOSIS; INFLAMMATION; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-1BETA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PRIONS; SCRAPIE;

MUS;

EID: 84869046062     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01340-12     Document Type: Article

References (35)

1. Andreoletti O, et al. 2002. Astrocytes accumulate 4-hydroxynonenal adducts in murine scrapie and human Creutzfeldt-Jakob disease. Neurobiol. Dis. 11:386-393.
2. Bencsik AA, Leclere E, Perron H, Moussa A. 2008. New insights into early sequential PrPsc accumulation in scrapie infected mouse brain evidenced by the use of streptomycin sulfate. Histochem. Cell Biol. 129:643-650.
3. Brown AR, et al. 2003. Inducible cytokine gene expression in the brain in the ME7/CV mouse model of scrapie is highly restricted, is at a strikingly low level relative to the degree of gliosis and occurs only late in disease. J. Gen. Virol. 84:2605-2611.
4. Bueler H, et al. 1994. High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol. Med. 1:19-30.
5. Chen Y, Swanson RA. 2003. Astrocytes and brain injury. J. Cereb. Blood Flow Metab. 23:137-149.
6. Cooper AM, Khader SA. 2007. IL-12p40: an inherently agonistic cytokine. Trends Immunol. 28:33-38.
7. Dheen ST, Kaur C, Ling EA. 2007. Microglial activation and its implications in the brain diseases. Curr. Med. Chem. 14:1189-1197.
8. Felton LM, et al. 2005. MCP-1 and murine prion disease: separation of early behavioural dysfunction from overt clinical disease. Neurobiol. Dis. 20:283-295.
9. Hanisch UK. 2002. Microglia as a source and target of cytokines. Glia 40:140-155.
10. Jana M, Dasgupta S, Saha RN, Liu X, Pahan K. 2003. Induction of tumor necrosis factor-alpha (TNF-α) by interleukin-12 p40 monomer and homodimer in microglia and macrophages. J. Neurochem. 86: 519-528.
11. Jana M, Pahan K. 2009. IL-12 p40 homodimer, but not IL-12 p70, in-duces the expression of IL-16 in microglia and macrophages. Mol. Immunol. 46:773-783.
12. Jeffrey M, Martin S, Barr J, Chong A, Fraser JR. 2001. Onset of accumulation of PrPres in murine ME7 scrapie in relation to pathological and PrP immunohistochemical changes. J. Comp. Pathol. 124:20-28.
13. Kielian T. 2004. Microglia and chemokines in infectious diseases of the nervous system: views and reviews. Front. Biosci. 9:732-750.
14. Klein MA, et al. 1997. A crucial role for B cells in neuroinvasive scrapie. Nature 390:687-690.
15. Klingeborn M, et al. 2011. Crucial role for prion protein membrane anchoring in the neuroinvasion and neural spread of prion infection. J. Virol. 85:1484-1494.
16. LaCasse RA, Striebel JF, Favara C, Kercher L, Chesebro B. 2008. Role of Erk1/2 activation in prion disease pathogenesis: absence of CCR1 leads to increased Erk1/2 activation and accelerated disease progression. J. Neuroimmunol. 196:16-26.
17. Lasmezas CI, et al. 1996. Strain specific and common pathogenic events in murine models of scrapie and bovine spongiform encephalopathy. J. Gen. Virol. 77(Pt 7):1601-1609.
18. Lefkowitz DL, Lefkowitz SS. 2008. Microglia and myeloperoxidase: a deadly partnership in neurodegenerative disease. Free Radic. Biol. Med. 45:726-731.
19. Mabbott NA, et al. 2000. Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie. J. Virol. 74:3338-3344.
20. Matsunaga Y, et al. 2001. Cryptic epitopes in N-terminally truncated prion protein are exposed in the full-length molecule: dependence of conformation on pH. Proteins 44:110-118.
21. Meade-White K, et al. 2007. Resistance to chronic wasting disease in transgenic mice expressing a naturally occurring allelic variant of deer prion protein. J. Virol. 81:4533-4539.
22. O'Shea M, et al. 2008. Investigation of Mcp1 as a quantitative trait gene for prion disease incubation time in mouse. Genetics 180:559-566.
23. Prinz M, Hausler KG, Kettenmann H, Hanisch U. 2001. β-Adrenergic receptor stimulation selectively inhibits IL-12p40 release in microglia. Brain Res. 899:264-270.
24. Prusiner SB. 1991. Molecular biology of prion diseases. Science 252:1515-1522.
25. Riemer C, et al. 2004. Gene expression profiling of scrapie-infected brain tissue. Biochem. Biophys. Res. Commun. 323:556-564.
26. - mice. J. Virol. 82:12464-12471.
27. Rock RB, et al. 2004. Role of microglia in central nervous system infections. Clin. Microbiol. Rev. 17:942-964.
28. Safar J, et al. 1998. Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 4:1157-1165.
29. Schultz J, et al. 2004. Role of interleukin-1 in prion disease-associated astrocyte activation. Am. J. Pathol. 165:671-678.
30. Song PJ, et al. 2010. Evaluation of prion deposits and microglial activation in scrapie-infected mice using molecular imaging probes. Mol. Imaging Biol. 12:576-582.
31. Stanton JB, Knowles DP, Call DR, Mathison BA, Baszler TV. 2009. Limited transcriptional response of ovine microglia to prion accumulation. Biochem. Biophys. Res. Commun. 386:345-350.
32. Striebel JF, Race B, Meade-White KD, LaCasse R, Chesebro B. 2011. Strain specific resistance to murine scrapie associated with a naturally occurring human prion protein polymorphism at residue 171. PLoS Pathog. 7:e1002275. doi:10.1371/journal.ppat.1002275.
33. Thackray AM, McKenzie AN, Klein MA, Lauder A, Bujdoso R. 2004. Accelerated prion disease in the absence of interleukin-10. J. Virol. 78: 13697-13707.
34. Tribouillard-Tanvier D, Carroll JA, Moore RA, Striebel JF, Chesebro B. 2012. Role of cyclophilin A from brains of prion-infected mice in stimulation of cytokine release by microglia and astroglia in vitro. J. Biol. Chem. 287:4628-4639.
35. Tribouillard-Tanvier D, Striebel JF, Peterson KE, Chesebro B. 2009. Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels. J. Virol. 83:11244-11253.